AP The Retina in Systemic Disease

Tracking # 20-1395027

$99999.00

There are no ratings for this course

Learn more

Educator AMERICAN ACADEMY OF OPTOMETRY

CE Broker Reporting Reported automatically

Method Lecture

Dates Sep 30, 2026 - Oct 3, 2026

Course overview

This course highlights some of the important retinal findings we may encounter that are associated with systemic diseases. Management tips, both ocular and systemic, are provided to help the primary care optometrist co-manage these patients with other health care providers, including primary care physicians and internists. Further when and what additional tests should be ordered, such as lab work or imaging, is emphasized.

Subject areas

This course counts toward the state boards and subject areas below.

Missouri Board of Optometry

Optometrist

2h Relevant to the Practice of Optometry

Texas Optometry Board

Optometric Glaucoma Specialist

2h Diagnostic / Therapeutic

Optometric Glaucoma Specialist Limited License

2h Diagnostic / Therapeutic

Optometrist

2h Diagnostic / Therapeutic

Therapeutic Optometrist

2h Diagnostic / Therapeutic

Therapeutic Optometrist Limited License

2h Diagnostic / Therapeutic

Disclosure statements

FERRUCCI: C-Apellis, Astellas, B&L,I-care, LENZ Therapeutics, LKC Technologies, Notal Vision, Science based Health, Visible genomics

MAJCHER: C-Astellas, Apellis, Regeneron, Optomed, LENX Therapeutics, Notal Vision, Topcon, Tarsus, Genentech, Carl Zeiss

YACKEY: C- Appelis, Astellas, Glauckos, Haag Streit, Notal Vison, Ocuterra, Orasis/Qlosi, RegenexBio, Reliance, Tarsus, Topcon, C=Visible genomics, Zeiss